Actively Recruiting
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
Led by University Hospital, Basel, Switzerland · Updated on 2025-12-26
100
Participants Needed
1
Research Sites
233 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Basel, Switzerland
Lead Sponsor
L
Luxembourg Institute of Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective cohort study is part of the Clinnova programme and aims to (i) identify clinical imaging and omics characteristics associated with early Multiple Sclerosis (MS) and with transitioning phases to progressive MS, as well as (ii) to investigate digital biomarkers allowing the continuous clinical monitoring of those patients.
CONDITIONS
Official Title
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years
- Willing and able to comply with study procedures including data and sample collection, visits, and examinations
- Signed informed consent form
- Own a smartphone compatible with the Healios+Me app (iOS or Android)
- Corrected close visual acuity of 0.5
- Hand motor skills sufficient to use a smartphone
- Ability to follow the study procedures
- Diagnosed with Multiple Sclerosis according to the revised McDonald criteria 2017, including all clinical forms
- Have early disease stage (< 3 years) or are in the transitioning phase to progressive disease as evaluated by EDSS
- Enrolled in the Swiss MS cohort (SMSC) at University Hospital Basel
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
Basel, Switzerland, 4031
Actively Recruiting
Research Team
B
Bebeka Cosandey (Clinnova:Scientific Project Lead), PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here